MyFinsight
Home
Blog
About
Adicet Bio, Inc. (ACET)
Adicet Bio, Inc. (ACET)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Free Cash flow
-$20,025K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Maturities of short term treasur...
Stock-based compensation expense
Stock-based compensation expense
Others
Negative Cash Flow Breakdown
Purchases of short-term treasury...
Net loss
Operating lease liability
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net loss
-21,358
-
-
-
Noncash lease expense
755
-
-
-
Stock-based compensation expense
1,441
-
-
-
Loss on disposal of property and equipment
0
-
-
-
Net amortization of premiums and accretion discounts on investments
633
-
-
-
Amortization of deferred transaction costs
0
-
-
-
Prepaid expenses and other current assets
93
-
-
-
Depreciation And Amortization
1,199
-
-
-
Other non-current assets
5
-
-
-
Accounts payable
664
-
-
-
Operating lease liability
-1,043
-
-
-
Accrued and other current and non-current liabilities
-750
-
-
-
Stock-based compensation expense
1,397
-
-
-
Net cash used in operating activities
-19,823
-
-
-
Purchases of short-term treasury securities
24,147
-
-
-
Maturities of short term treasury securities
-41,000
-
-
-
Purchases of property and equipment
202
-
-
-
Net cash provided by investing activities
16,651
-
-
-
Proceeds from exercise of stock options
1
-
-
-
Proceeds from employee stock purchase plan
82
-
-
-
Pre-funded warrant issuance costs
22
-
-
-
Taxes withheld and paid related to net share settlement of equity awards
-3
-
-
-
Net cash used in financing activities
58
-
-
-
Net change in cash, cash equivalents and restricted cash
-3,114
-
-
-
Cash and cash equivalents
33,131
-
-
-
Restricted cash
2,869
-
-
-
Net loss
-21,358
-20,244
-30,516
-26,856
Depreciation and amortization expense
1,199
1,342
1,473
1,573
Noncash lease expense
755
743
1,028
682
Stock-based compensation expense
1,441
1,303
5,650
2,529
Loss on disposal of property and equipment
0
-
0
0
Net amortization of premiums and accretion discounts on investments
633
790
1,212
705
Amortization of deferred transaction costs
0
0
28
15
Prepaid expenses and other current assets
93
85
-1,191
619
Other non-current assets
5
-3
-4
-116
Accounts payable
664
-1,800
307
1,213
Operating lease liability
-1,043
-817
-796
-778
Accrued and other current and non-current liabilities
-750
-1,145
1,934
538
Net cash used in operating activities
-19,823
-21,490
-20,909
-22,307
Purchases of short-term treasury securities
24,147
20,084
79,545
26,955
Maturities of short term treasury securities
-41,000
-39,000
-35,000
-44,000
Purchases of property and equipment
202
37
-10
209
Net cash provided by investing activities
16,651
18,879
-44,535
16,836
Proceeds from issuance of common stock pursuant to at-the-market offering, net of issuance costs
-
-
0
0
Proceeds from issuance of common stock and pre-funded warrants pursuant to underwritten public offering, net of issuance costs
-
-
75,172
0
Proceeds from exercise of stock options
1
-
1
0
Proceeds from employee stock purchase plan
82
-
59
0
Pre-funded warrant issuance costs
22
-
-
-
Taxes withheld and paid related to net share settlement of equity awards
-3
-65
0
0
Principal payments on finance leases
-
-
0
150
Net cash used in financing activities
58
-65
75,232
-150
Net change in cash, cash equivalents and restricted cash
-3,114
-2,676
9,788
-5,621
Cash, cash equivalents and restricted cash at the beginning of period
39,114
41,790
32,002
59,398
Cash, cash equivalents and restricted cash at the end of period
36,000
39,114
41,790
32,002
Cash, cash equivalents and restricted cash in consolidated balance sheets
36,000
-
-
-
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Maturities of short term
treasury securities
-$41,000K
(37.88%↑ Y/Y)
Proceeds from employee
stock purchase plan
$82K
(-69.29%↓ Y/Y)
Proceeds from exercise of
stock options
$1K
Net cash provided by
investing activities
$16,651K
(-44.67%↓ Y/Y)
Net cash used in
financing activities
$58K
(-64.42%↓ Y/Y)
Stock-based compensation
expense
$1,441K
(-76.33%↓ Y/Y)
Canceled cashflow
$24,349K
Canceled cashflow
$25K
Noncash lease expense
$755K
(-54.87%↓ Y/Y)
Net change in cash,
cash equivalents and...
-$3,114K
(85.70%↑ Y/Y)
Canceled cashflow
$16,709K
Stock-based compensation
expense
$1,397K
(-77.05%↓ Y/Y)
Depreciation And
Amortization
$1,199K
(-64.05%↓ Y/Y)
Accounts payable
$664K
(235.23%↑ Y/Y)
Canceled cashflow
$997K
Purchases of short-term
treasury securities
$24,147K
(-29.74%↓ Y/Y)
Purchases of property and
equipment
$202K
(-86.87%↓ Y/Y)
Pre-funded warrant
issuance costs
$22K
Taxes withheld and
paid related to net...
-$3K
(97.12%↑ Y/Y)
Net cash used in
operating activities
-$19,823K
(61.90%↑ Y/Y)
Canceled cashflow
$3,260K
Net amortization of
premiums and accretion...
$633K
(-70.91%↓ Y/Y)
something is missing
-$271K
Prepaid expenses and
other current assets
$93K
(108.39%↑ Y/Y)
Net loss
-$21,358K
(64.06%↑ Y/Y)
Operating lease liability
-$1,043K
(44.37%↑ Y/Y)
Accrued and other
current and non-current...
-$750K
(-32.04%↓ Y/Y)
Buy us a coffee